The result showed a strong correlation between LAMTOR4 and RPS6 (R > 0.3, p-value < 0.001) with TNFSF13B expression, suggesting a possible correlation between the increasing activity of the mTOR signaling pathway and DLBCL progression in pSS patients (Figure 3C). The gene discussed is LAMTOR4; the disease is diffuse large B-cell lymphoma.